ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Hot Features

Registration Strip Icon for alerts Regístrate para obtener alertas en tiempo real, cartera personalizada y movimientos del mercado.

NERV Minerva Neurosciences Inc

2.37
0.02 (0.85%)
03 May 2024 - Cerrado
Retrasado por 15 minutos
Nombre de la Acción Símbolo de la Acción Bolsa de Valores Tipo de Valor
Minerva Neurosciences Inc NERV NASDAQ Acción Común
  Variación del Día (ptos.) Variación del Día (%) Último Precio Hora
0.02 0.85% 2.37 23:00:06
Precio de Apertura Precio Mínimo Precio Máximo Precio de cierre Precio Anterior
2.39 2.36 2.41 2.37 2.35
más cotizaciones de acciones »

Noticias Recientes

Fecha Hora Fuente Noticia
01/5/202406:30GLOBEMinerva Neurosciences Reports First Quarter 2024 Financial..
27/2/202407:04EDGAR2Form 8-K - Current report
27/2/202407:00GLOBEMinerva Neurosciences Receives Complete Response Letter from..
22/2/202406:00GLOBEMinerva Neurosciences Reports Fourth Quarter and Fiscal Year..
22/2/202405:30EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
07/11/202306:30GLOBEMinerva Neurosciences Reports 2023 Third Quarter Financial..
07/11/202306:00EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
05/10/202315:34EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/10/202315:33EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/9/202307:58EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/9/202307:57EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28/9/202315:05EDGAR2Form 8-K - Current report
15/8/202308:28EDGAR2Form ARS - Annual Report to Security Holders
15/8/202308:26EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
15/8/202308:25EDGAR2Form DEF 14A - Other definitive proxy statements
09/8/202316:12EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
04/8/202307:07EDGAR2Form S-3 - Registration statement under Securities Act of..
01/8/202306:30GLOBEMinerva Neurosciences Reports 2023 Second Quarter Financial..
01/8/202306:01EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
07/7/202315:18EDGAR2Form SC 13D - General statement of acquisition of beneficial..
28/6/202307:37EDGAR2Form 8-K - Current report
28/6/202307:30GLOBEMinerva Neurosciences Announces $20 Million in Private..
15/5/202306:30GLOBEMinerva Neurosciences Reports 2023 First Quarter Financial..
10/5/202307:00GLOBEMinerva Neurosciences Announces Update on its New Drug..
08/5/202307:30GLOBEMinerva Neurosciences to Report First Quarter 2023 Financial..

Su Consulta Reciente

Delayed Upgrade Clock